» Articles » PMID: 39164756

Exosomal MiRNAs: the Tumor's Trojan Horse in Selective Metastasis

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2024 Aug 20
PMID 39164756
Authors
Affiliations
Soon will be listed here.
Abstract

Organs of future metastasis are not passive receivers of circulating tumor cells, but are instead selectively and actively modified by the primary tumor before metastatic spread has even occurred. Tumors orchestrate a pre-metastatic program by conditioning distant organs to create microenvironments that foster the survival and proliferation of tumor cells before their arrival, thereby establishing pre-metastatic niches. Primary tumor-derived exosomes modulate these pre-metastatic niches, generating a permissive environment that facilitates the homing and expansion of tumor cells. Moreover, microRNAs have emerged as a key component of exosomal cargo, serving not only to induce the formation of pre-metastatic niches but also to prime these sites for the arrival and colonization of specific secondary tumor populations. Against this backdrop, this review endeavors to elucidate the impact of tumor-derived exosomal microRNAs on the genesis of their individualized pre-metastatic niches, with a view towards identifying novel means of specifying cancer metastasis and exploiting this phenomenon for cancer immunotherapy.

Citing Articles

LncRNA-MALAT1 promotes triple-negative breast cancer progression and function as ceRNA to target REEP5 by sponging miR-106a-5p.

Yang Q, Fu Y, Feng W, Mao J, Xu N, Liu Q Eur J Med Res. 2025; 30(1):159.

PMID: 40059235 PMC: 11892299. DOI: 10.1186/s40001-025-02420-x.


Glioblastoma- derived exosomes (GBM-Exo) regulate microglial M2 polarization via the RAC1/AKT/NRF2 pathway.

Wu Q, Chen S, Xie X, Yan H, Feng X, Su G J Neurooncol. 2025; .

PMID: 40019712 DOI: 10.1007/s11060-024-04934-6.


Bile's Hidden Weapon: Modulating the Microbiome and Tumor Microenvironment.

Saadh M, Ahmed H, Al-Hussainy A, Kaur I, Kumar A, Chahar M Curr Microbiol. 2024; 82(1):25.

PMID: 39614901 DOI: 10.1007/s00284-024-04004-0.


Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment.

Guan Y, Zhang W, Mao Y, Li S Mol Cancer. 2024; 23(1):246.

PMID: 39487487 PMC: 11529338. DOI: 10.1186/s12943-024-02161-1.

References
1.
Xu G, Zhang B, Ye J, Cao S, Shi J, Zhao Y . Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression. Int J Biol Sci. 2019; 15(11):2320-2329. PMC: 6775321. DOI: 10.7150/ijbs.33750. View

2.
Zhu M, Zhang N, He S, Lu X . Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7. Cell Cycle. 2020; 19(10):1200-1221. PMC: 7217357. DOI: 10.1080/15384101.2020.1749467. View

3.
Zhang Y, Zhao J, Ding M, Su Y, Cui D, Jiang C . Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis. J Exp Clin Cancer Res. 2020; 39(1):282. PMC: 7734763. DOI: 10.1186/s13046-020-01761-1. View

4.
Pucci M, Raimondo S, Urzi O, Moschetti M, Di Bella M, Conigliaro A . Tumor-Derived Small Extracellular Vesicles Induce Pro-Inflammatory Cytokine Expression and PD-L1 Regulation in M0 Macrophages via IL-6/STAT3 and TLR4 Signaling Pathways. Int J Mol Sci. 2021; 22(22). PMC: 8621495. DOI: 10.3390/ijms222212118. View

5.
Dou R, Liu K, Yang C, Zheng J, Shi D, Lin X . EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer. Clin Transl Med. 2021; 11(12):e595. PMC: 8694332. DOI: 10.1002/ctm2.595. View